Protalix BioTherapeutics, Inc. (PLX) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | 18.95M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $18.95M | (m) |
| 2026-03-31 | (m) | $15.33M | (m) |
| 2025-12-31 | (m) | $-6.60M | (m) |
| 2025-09-30 | (m) | $5.39M | (m) |
| 2025-06-30 | (m) | $6.28M | (m) |
| 2025-03-31 | (m) | $3.91M | (m) |
| 2024-12-31 | (m) | $2.93M | (m) |
| 2024-09-30 | (m) | $-9.61M | (m) |
| 2024-06-30 | (m) | $-14.69M | (m) |
| 2024-03-31 | (m) | $6.85M | (m) |
| 2023-12-31 | (m) | $8.31M | (m) |
| 2023-09-30 | (m) | $10.62M | (m) |
| 2023-06-30 | (m) | $8.90M | (m) |
| 2023-03-31 | (m) | $-15.77M | (m) |
| 2022-12-31 | (m) | $-14.93M | (m) |
| 2022-09-30 | (m) | $-17.85M | (m) |
| 2022-06-30 | (m) | $-18.49M | (m) |
| 2022-03-31 | (m) | $-24.39M | (m) |
| 2021-12-31 | (m) | $-27.58M | (m) |
| 2021-09-30 | (m) | $-20.52M | (m) |
| 2021-06-30 | (m) | $-20.76M | (m) |
| 2021-03-31 | (m) | $-13.66M | (m) |
| 2020-12-31 | (m) | $-6.52M | (m) |
| 2020-09-30 | (m) | $-6.63M | (m) |
| 2020-06-30 | (m) | $-5.75M | (m) |
| 2020-03-31 | (m) | $-9.35M | (m) |
| 2019-12-31 | (m) | $-18.28M | (m) |
| 2019-09-30 | (m) | $-24.00M | (m) |
| 2019-06-30 | (m) | $-25.76M | (m) |
| 2019-03-31 | (m) | $-26.48M | (m) |
| 2018-12-31 | (m) | $-26.46M | (m) |
| 2018-09-30 | (m) | $-51.38M | (m) |
| 2018-06-30 | (m) | $-47.27M | (m) |
| 2018-03-31 | (m) | $-35.53M | (m) |
| 2017-12-31 | (m) | $-85.28M | (m) |
| 2017-09-30 | (m) | $-72.76M | (m) |
| 2017-06-30 | (m) | $-68.61M | (m) |
| 2017-03-31 | (m) | $-79.92M | (m) |
| 2016-12-31 | (m) | $-29.36M | (m) |
| 2016-09-30 | (m) | $46.16M | (m) |
| 2016-06-30 | (m) | $49.63M | (m) |
| 2016-03-31 | (m) | $55.41M | (m) |
| 2015-12-31 | (m) | $58.04M | (m) |
| 2015-09-30 | (m) | $-23.33M | (m) |
| 2015-06-30 | (m) | $-27.52M | (m) |
| 2015-03-31 | (m) | $-28.57M | (m) |
| 2014-12-31 | (m) | $-29.94M | (m) |
| 2014-09-30 | (m) | $-32.36M | (m) |
| 2014-06-30 | (m) | $-30.10M | (m) |
| 2014-03-31 | (m) | $-30.81M | (m) |
| 2013-12-31 | (m) | $-27.79M | (m) |
| 2013-09-30 | (m) | $-26.78M | (m) |
| 2013-06-30 | (m) | $-26.51M | (m) |
| 2013-03-31 | (m) | $-10.04M | (m) |
| 2012-12-31 | (m) | $-11.62M | (m) |
| 2012-09-30 | (m) | $-10.65M | (m) |
| 2012-06-30 | (m) | $-14.05M | (m) |
| 2012-03-31 | (m) | $-37.38M | (m) |
| 2011-12-31 | (m) | $-36.53M | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $-29.00M | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | (m) | $-31.44M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |